Notice of Intent to issue a Sole Source Award for Research and Development of 10,000 lateral flow devices for pre-clinical and clinical studies to rapidly detect HIV
Contract Opportunity Analysis
The Centers for Disease Control and Prevention, through the CDC Office of Acquisition Services and the Division of HIV Prevention, intends to award a sole-source firm fixed-price purchase order to Beacon Scientific Inc. for the manufacture of 10,000 lateral flow devices to support pre-clinical and clinical studies of rapid HIV detection in point-of-care settings. The work focuses on producing devices for evaluating their performance and utility in detecting HIV antiretroviral usage, and the justification cites Beacon Scientific’s proprietary nanoparticle materials as the basis for its capability. Performance is associated with San Diego, California, and the acquisition is described as commercial services under NAICS 541714. This notice is not a request for competitive quotations, but any response received within 15 days of the notice will be considered and should be emailed to zvm0@cdc.gov by 06/02/2026.